Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lena E Friberg

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Clinical Pharmacology and Therapeutics|February 1, 2021
Pivotal Role of Translation in Anti-Infective DevelopmentLena E Friberg
Frontiers in Pharmacology|April 1, 2020
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase InhibitorsMaddalena Centanni, Lena E Friberg
Investigational New Drugs|August 2, 2003
Mechanistic models for myelosuppressionLena E Friberg, Mats O Karlsson
Cancer Chemotherapy and Pharmacology|November 8, 2011
The shape of the myelosuppression time profile is related to the probability of developing neutropenic fever in patients with docetaxel-induced grade IV neutropeniaEmma K Hansson, Lena E Friberg
CPT: Pharmacometrics & Systems Pharmacology|October 4, 2022
Bayesian forecasting of tumor size metrics and overall survivalSreenath M Krishnan, Lena E Friberg
Pharmacological Reviews|June 28, 2013
Pharmacokinetic-pharmacodynamic modeling of antibacterial drugsElisabet I Nielsen, Lena E Friberg
International Journal of Antimicrobial Agents|June 8, 2024
Impact of continuous-infusion meropenem degradation and infusion bag changes on bacterial killing of Pseudomonas aeruginosa based on model-informed translationIris K Minichmayr, Lena E Friberg
CPT: Pharmacometrics & Systems Pharmacology|October 11, 2025
Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric FrameworkEman I K Ibrahim, Lena E Friberg
Jac-Antimicrobial Resistance|April 14, 2025
Simulation-based evaluation of the impact of dose fractionation study design on antibiotic PKPD analysesRaphaël Saporta, Muskan Madan, Lena E Friberg
Journal of Pharmacokinetics and Pharmacodynamics|October 11, 2015
Inter occasion variability in individual optimal designAnders N Kristoffersson, Lena E Friberg, Joakim Nyberg
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Clinical Pharmacology and Therapeutics|February 1, 2021
Pivotal Role of Translation in Anti-Infective DevelopmentLena E Friberg
Frontiers in Pharmacology|April 1, 2020
Model-Based Biomarker Selection for Dose Individualization of Tyrosine-Kinase InhibitorsMaddalena Centanni, Lena E Friberg
Investigational New Drugs|August 2, 2003
Mechanistic models for myelosuppressionLena E Friberg, Mats O Karlsson
Cancer Chemotherapy and Pharmacology|November 8, 2011
The shape of the myelosuppression time profile is related to the probability of developing neutropenic fever in patients with docetaxel-induced grade IV neutropeniaEmma K Hansson, Lena E Friberg
CPT: Pharmacometrics & Systems Pharmacology|October 4, 2022
Bayesian forecasting of tumor size metrics and overall survivalSreenath M Krishnan, Lena E Friberg
Pharmacological Reviews|June 28, 2013
Pharmacokinetic-pharmacodynamic modeling of antibacterial drugsElisabet I Nielsen, Lena E Friberg
International Journal of Antimicrobial Agents|June 8, 2024
Impact of continuous-infusion meropenem degradation and infusion bag changes on bacterial killing of Pseudomonas aeruginosa based on model-informed translationIris K Minichmayr, Lena E Friberg
CPT: Pharmacometrics & Systems Pharmacology|October 11, 2025
Optimizing Ibrutinib Posology in Chronic Lymphocytic Leukemia Using a Semi-Mechanistic Pharmacometric FrameworkEman I K Ibrahim, Lena E Friberg
Jac-Antimicrobial Resistance|April 14, 2025
Simulation-based evaluation of the impact of dose fractionation study design on antibiotic PKPD analysesRaphaël Saporta, Muskan Madan, Lena E Friberg
Journal of Pharmacokinetics and Pharmacodynamics|October 11, 2015
Inter occasion variability in individual optimal designAnders N Kristoffersson, Lena E Friberg, Joakim Nyberg
Pageof 19